MLH1 and neoplasm: A single sample derived from an AR NR patient was classified as hypermutated as it presented a missense mutation in exon 19 of the MLH1 gene, leading to 1,511 variants just in this particular tumor sample, a significantly higher number as compared to non-hypermutated tumors, which presented a median of 59 somatic variants.